Clinical Efficacy of Pneumococcal Conjugate 13-Valent Vaccine in Young Children

Pediatric pharmacology
doi 10.15690/pf.v13i5.1639
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Paediatrician Publishers LLC

Related search

Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared With 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Recommendations for the Prevention of Streptococcus Pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)

Pediatrics
Child HealthPediatricsPerinatology
2010English

Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization Program

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2000English

Public and Private Payer Perspectives on the Net Cost of Implementation of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Postlicensure Safety Surveillance for 7-Valent Pneumococcal Conjugate Vaccine

JAMA - Journal of the American Medical Association
Medicine
2004English

Effect of Use of 13-Valent Pneumococcal Conjugate Vaccine in Children on Invasive Pneumococcal Disease in Children and Adults in the USA: Analysis of Multisite, Population-Based Surveillance

The Lancet Infectious Diseases
Infectious Diseases
2015English

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy